Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals
- PMID: 27923721
- DOI: 10.1016/j.cgh.2016.11.030
Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals
Comment in
-
Reply.Clin Gastroenterol Hepatol. 2017 Apr;15(4):605-606. doi: 10.1016/j.cgh.2016.12.016. Epub 2016 Dec 23. Clin Gastroenterol Hepatol. 2017. PMID: 28025157 No abstract available.
Comment on
-
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.Clin Gastroenterol Hepatol. 2017 Jan;15(1):132-136. doi: 10.1016/j.cgh.2016.06.023. Epub 2016 Jul 5. Clin Gastroenterol Hepatol. 2017. PMID: 27392759
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical